Browse by Profession PharmaciesHospitalsDoctorsPatientsManufacturers

Place an Order

  • first
  • second
  • third

News

  • Rare Disease Day 29th February, 2012, Patients and Researchers, Partners for Life!

  • On 29th February, 2012 the National Institute of Health (NIH) will celebrate the 5th annual Rare Disease Day with a day-long celebration and recognition of the various rare diseases and research activities supported by the NIH Office of Rare Diseases Research, the NIH Clinical Centre, other NIH Institutes and Centres; the Food and Drug Administration's Office of Orphan Product Development; the National Organisation for Rare Disorders; and the Genetic Alliance. Rare Disease Day at NIH (RDD@NIH) will be held in the Clinical Centre's Masur Auditorium (Building 10) from 8:30 am to 5:00 pm. Attendance is free and it is open to the public.

    Please follow the link below to find out more about Rare Disease Day:

  • Tue 14th Dec 2010Read More

  • Information on Unlicensed Products: Mastocytosis

  • Mastocytosis is a rare disease that occurs in both children and adults. It is characterized by the presence of too many mast cells in connective tissues such as the skin, the lining of the stomach, intestine and other sites. Mast cells play a critical role in the immune system’s response to defend the body against infection and disease. 

  • Tue 14th Dec 2010Read More

Welcome

Masters Pharmaceuticals is a global specialty healthcare company with a heritage of over 25 years working with Manufacturers, Hospitals, Pharmacists, Governments and individual patients with the singular objective of 'Improving lives through patient access'. With strategic locations across 4 continents, Masters is uniquely poised to offer a truly global solution to your supply needs.

View the Masters brochure (PDF)

Testimonial

"Masters sourced and imported critical comparator medicines for our clinical trial work in Brazil and we were confident that it was done in the correct and legal way, ensuring that the integrity of the product and the supply chain was maintained throughout"

AstraZeneca

"Patients waiting for Mircera approval (Roche medication for anemia / chronic renal illness), had the option of importing the product through Masters. The Nephrologists that prescribed the medication were extremely satisfied with the safety, speed and ease to access. For the patients, it was the chance to get access to the medication even before the product was approved"

Roche Pharmaceuticals

"Masters have enabled us to supply a 'life saving' medication on a legal and secure basis whereby previously the only channels open were those of dubious integrity and at a prohibitive cost

Endocrinovet

"As a global player in the hospital planning / construction / management business, we turned to Masters in assisting us build a robust, secure and cost effective Pharma procurement strategy in the Caribbean market. During the 1st year we have benefited from a significant improvement in both service and cost saving"

InterHealthCanada (TCI) Ltd